María del Pilar de la Huerta Martínez
Finanzdirektor/CFO bei BIOFRONTERA AG
Aktive Positionen von María del Pilar de la Huerta Martínez
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
4BASEBIO PLC | Direktor/Vorstandsmitglied | 22.12.2020 | - |
Independent Dir/Board Member | 22.12.2020 | - | |
BIOFRONTERA AG | Finanzdirektor/CFO | 12.09.2022 | - |
Epidesease SL | Direktor/Vorstandsmitglied | - | - |
Vaxdyn SL
Vaxdyn SL BiotechnologyHealth Technology Vaxdyn SL discovers and develops antigens. Its products include pipeline, clinical need and R&D programs. The company was founded by Jeronimo Pachon, Pilar Perez-Romero and Michael J. McConnell in 2011 and is headquartered in Seville, Spain. | Direktor/Vorstandsmitglied | - | - |
Biofrontera Pharma GmbH
Biofrontera Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005. | Vorstandsvorsitzender | - | - |
Karriereverlauf von María del Pilar de la Huerta Martínez
Ehemalige bekannte Positionen von María del Pilar de la Huerta Martínez
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
2INVEST AG | Direktor/Vorstandsmitglied | 07.07.2017 | 03.11.2020 |
Vorstandsvorsitzender | 17.10.2012 | 07.07.2017 | |
Finanzdirektor/CFO | 17.10.2012 | 01.03.2017 | |
Antibióticos de León SLU
Antibióticos de León SLU Pharmaceuticals: MajorHealth Technology Antibióticos de León SLU develops, manufactures, sells, and distributes active pharmaceutical ingredients for penicillin-based antibiotics. Its products include sterile antibiotics and oral semisynthesis. The company was founded in 2014 and is headquartered in Leon, Spain. | Direktor/Vorstandsmitglied | 01.07.2017 | 25.04.2018 |
Vorstandsvorsitzender | 01.07.2017 | 25.04.2018 | |
BIOTECHNOLOGY ASSETS, S.A. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Genetrix SL
Genetrix SL BiotechnologyHealth Technology Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain. | Vorstandsvorsitzender | 01.01.2010 | - |
░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - | |
░░░░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von María del Pilar de la Huerta Martínez
Universidad Complutense de Madrid | Undergraduate Degree |
Statistik
International
Spanien | 10 |
Deutschland | 4 |
Vereinigtes Königreich | 2 |
Operativ
Chief Executive Officer | 7 |
Director/Board Member | 7 |
Director of Finance/CFO | 2 |
Sektoral
Health Technology | 8 |
Commercial Services | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
2INVEST AG | Finance |
BIOTECHNOLOGY ASSETS, S.A. | Health Technology |
4BASEBIO PLC | Health Technology |
BIOFRONTERA AG | Health Technology |
Private Unternehmen | 8 |
---|---|
Araclon Biotech SL
Araclon Biotech SL Miscellaneous Commercial ServicesCommercial Services Araclon Biotech SL researches and develops therapies and diagnostic methods for Alzheimer’s disease. Its research areas include early diagnosis of Alzheimer’s disease; therapy for Alzheimer’s disease; development of a predictive test for the Alzheimer’s disease in asymptomatic individuals; and development of therapy for Parkinson’s disease. The company was founded on January 27, 2004 and is headquartered in Zaragoza, Spain. | Commercial Services |
Noscira SA
Noscira SA Miscellaneous Commercial ServicesCommercial Services Noscira SA develops and manufactures pharmaceutical products. It focuses on developing drugs for the treatment of nervous system disorders, especially the Alzheimer's disease. The company was founded in 2000 and is headquartered in Tres Cantos, Spain | Commercial Services |
Zeltia SA
Zeltia SA BiotechnologyHealth Technology Zeltia SA is a holding company, which develops marine-based drugs in the field of oncology. It operates through the Biopharmaceuticals and Consumer Chemicals segments. The Biopharmaceuticals segment engages in the research and marketing of anti-tumor drugs, diagnosis kits, and development of therapies based on reducing or silencing gene expression. The Consumer Chemicals segment produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and related products. The company was founded on August 3, 1939 and is headquartered in Madrid, Spain. | Health Technology |
Genetrix SL
Genetrix SL BiotechnologyHealth Technology Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain. | Health Technology |
Antibióticos de León SLU
Antibióticos de León SLU Pharmaceuticals: MajorHealth Technology Antibióticos de León SLU develops, manufactures, sells, and distributes active pharmaceutical ingredients for penicillin-based antibiotics. Its products include sterile antibiotics and oral semisynthesis. The company was founded in 2014 and is headquartered in Leon, Spain. | Health Technology |
Epidesease SL | |
Vaxdyn SL
Vaxdyn SL BiotechnologyHealth Technology Vaxdyn SL discovers and develops antigens. Its products include pipeline, clinical need and R&D programs. The company was founded by Jeronimo Pachon, Pilar Perez-Romero and Michael J. McConnell in 2011 and is headquartered in Seville, Spain. | Health Technology |
Biofrontera Pharma GmbH
Biofrontera Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005. | Commercial Services |